Triheptanoin

Study of Triheptanoin for the Prevention of Hypoglycemia in Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)

Expanded Access to Triheptanoin

Study to Evaluate the Use of Triheptanoin in Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)

Triheptanoin for Children With Primary-Specific Pyruvate Dehydrogenase Complex (PDC) Deficiency

A Study to Determine the Effect of Triheptanoin Compared With Even-Chain MCT on MCEs in Pediatric Patients With LC-FAOD

Pilot Study, Comparative, Single-center, Randomized, Crossover, Double-blind, Against Placebo, Testing the Effectiveness of Triheptanoin Oil in Alternating Hemiplegia of Childhood

Triheptanoin in Mc Ardle

Diet Treatment Glucose Transporter Type 1 Deficiency (G1D)

The Effect of Triheptanoin on Fatty Acid Oxidation and Exercise Tolerance in Patients With Glycogenoses

Compatibility of C7 With Ketogenic Diet in Patients Diagnosed With G1D

Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With a Novel Form of Anaplerosis

Treatment Development of Triheptanoin (G1D)

Anaplerotic Therapy Using Triheptanoin for Patients With Glycogen Storage Disease Type I

Compassionate Use of Triheptanoin (C7) for Inherited Disorders of Energy Metabolism

An Open-Label Trial of Triheptanoin in Patients With Glucose Transporter Type-1 Deficiency Syndrome

Treatment of Mitochondrial Dysfunction in Rett Syndrome With Triheptanoin

A Pilot Trial of Triheptanoin for People With Amyotrophic Lateral Sclerosis (PALS)

Treatment Development for Glucose Transporter Type I Deficiency Syndrome (G1D)

The Effect of Triheptanoin in Adults With McArdle Disease (Glycogen Storage Disease Type V)

Post Study Continuation of C7 for G1D